News

• Cipla Ltd, Plot D-27, Unit II - Desk Assessment

Desogestrel (WHOAPI-479) manufactured by Hunan  KYF Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

The invitation to Manufacturers of Antimalarial Medicines to submit an Expre

The Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interes

Lamivudine, manufactured by SMS Pharmaceuticals Limited, has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

The survey on the updated Post PQ Change Request process and PQDx 121 guidance shows that manufacturers are broadly satisfied with recent improvements to the system.

WHOAPI-429 (tenofovir disoproxil fumarate) manufactured by Styrax Pharma Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

A Position Note on Accessories has been published by the Assessment of Medical Devices Team.

New WHO Public Inspection Reports (WHOPIRs) were published today:

On 11 February 2026 WHO published an amended invitation to manufacturers of Monkeypox virus IVDs

New WHO Public Inspection Reports (WHOPIRs) were published today:

This survey aims to gather feedback on the updated PQDx 121 guidance, the new change request submission form, and the overall submission and assessment process.

WHO is pleased to announce that the Prequalification of IVDs programme scope has been expanded to the following types of products:  

On 18th December the Loopamp MTBC Detection Kit manufactured by Eiken Chemical Co., Ltd. was prequalified.

WHO Prequalification Unit (PQT) added the below new products to its prequalified list: 

Levonorgestrel manufactured by Jiangsu Lianhuan Pharmaceutical Co., Ltd.

The Prequalification of IVDs Q4 2025 Newsletter has been posted on the website.

Related links:  

For the first time, two SARS-CoV-2 antigen detection rapid tests have successfully transitioned from WHO’s Emergency Use Listing (EUL) to WHO Prequalification (PQ):

On 17 December 2025 the Assessment of Medical Devices Team held a webinar for stakeholders to introduce changes which will be implemented to the prequalification assessment

WHO recently hosted a successful workshop in The Westin Guangzhou, Guangzhou, China, bringing together over

The Monkeypox Virus (MPXV) Fast Real Time PCR Kit manufactured by Jiangsu Bioperfectus Technologies Co., Ltd.

WHO Prequalification Unit (PQT) added the below new products to its prequalified list: 

The invitation to Manufacturers of Antimalarial Medicines to submit an Expression of Interest for Product Evaluation to t

The Collaboration for Global Health

The following API was deleted: 

WHO Prequalification Unit (PQT) added the below new products to its prequalified list: 

WHO’s Prequalification of In Vitro Diagnostics

During the week of 27–31 October 2025, the World Health Organization (WHO) publ

Cowingene Monkeypox Typing Detection Kit, manufactured by Taizhou Cowingene Biotech Co., Ltd., has been listed under the WHO Emergency Use Listing (EUL).

&nb

These assays - Aptima HPV 16 18/45 Genotype Assay and the Aptima HPV Assay provide advanced nucleic acid amplification technology for detecting high-risk HPV type

In September 2023, PQT/MED issued a call to manufacturers to revisit and update their risk assessments for Finished Pharmaceutical Products (FPP) containing APIs with vulnerable amine groups.

The PQT/AMD team has added a new product to the Emergency Use Listing (EUL):

During the week of 20–24 October 2025, the World Health Organization (WHO) published updates to several WHO’s Public Assessment Reports (WHOPARs) on its In Vitro Diagnostics (IV

The PQT Medicines 8th Annual Medicines Quality Workshop for Manufacturers will take place from 27 to 30 October 2025.

In a continuing effort to best support the MPXV response, the Prequalification Unit has listed the Monkeypox Virus

The World Health Organization (WHO) has prequalified the Xpert MTB/XDR test, a quality-assured molecular diagnostic tool that enables rapid drug susceptibility testing (DST) for tuberculosis (TB).

WHO has prequalified two more products:

The BD Onclarity™ HPV Assay for the BD COR™ System is an amplified DNA test for the qualitative dete

A core component of the Prequalification assessment process relates to technical review of the product dossier and change requests.